Skip to content

Category: Articles

Eva Harris (far right) has led a dengue study in Nicaragua that for more than 12 years has regularly taken blood samples from children. Alejandro Belli/PLOS Pathogens

New evidence that dengue antibodies trigger life-threatening infections

It’s a disease theory fit for a spy novel: Protective antibodies can turn double agent, teaming up with the dengue virus to make an infection…

Continue reading New evidence that dengue antibodies trigger life-threatening infections

Comments closed

Variations of the CRISPR DNA editor can change one DNA base into another. Shaury Nash/Flickr (CC BY SA 2.0)

Novel CRISPR-derived ‘base editors’ surgically alter DNA or RNA, offering new ways to fix mutations

Since the start of the CRISPR craze 5 years ago, scientists have raced to invent ever-more-versatile or efficient variations of this powerful tool, which vastly…

Continue reading Novel CRISPR-derived ‘base editors’ surgically alter DNA or RNA, offering new ways to fix mutations

Comments closed

Americans have conflicting views on how technologies that allow human genome editing, such as one that uses the Cas9 enzyme to snip DNA, should be employed. Meletios/shutterstock

Americans are becoming more open to human genome editing, survey finds, but concerns remain

CRISPR, the powerful genome-editing tool, does a molecular tango to cut and modify DNA that is highly nuanced. The same subtlety applies to the public’s…

Continue reading Americans are becoming more open to human genome editing, survey finds, but concerns remain

Comments closed

The European Patent Office has signaled that it intends to grant MilliporeSigma a key CRISPR patent. vchal/shutterstock

CRISPR patent battle in Europe takes a ‘wild’ twist with surprising player

MilliporeSigma, a subsidiary of pharmaceutical giant Merck KGaA of Darmstadt, Germany, has become a new major player in the complicated European patent battles over CRISPR,…

Continue reading CRISPR patent battle in Europe takes a ‘wild’ twist with surprising player

Comments closed